CCL2 and neoplasm: This principally occurs through potent upregulation of chemoattractants in the tumour microenvironment (TME) for circulating monocytes, including colony stimulating factor 1 (CSF-1) and monocyte chemoattractant protein-1 (MCP-1) [57].